Further support for our results and hypothesis comes from survival curve analysis of HAGLR in breast and cervical cancer based on gene expression levels [41], showing that low levels of HAGLR are associated with patients’ survival (Figure 1G). The gene discussed is HAGLR; the disease is cervical carcinoma.